Good News In Pancreatic Cancer
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of Medicine, John Kauffman Family Professor For Pancreatic Cance...
Author: obr
Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts
Data Regarding Abraxane, Gemcitabine Plus Nivolumab Combo Study In Pancreatic Cancer
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses Data Regarding Abraxane,...
Author: obr
Added: 02/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2019 Category: Cancer & Oncology Source Type: podcasts
Screening Patients At High Risk For Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Screening Patients At Hi...
Author: obr
Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Opinion On NGS And BRCA Gene Testing In Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Opinion On NGS And BRCA ...
Author: obr
Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Neoadjuvant Chemotherapy & Upfront Surgery In Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Neoadjuvant Chemotherapy...
Author: obr
Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Promising Novel Therapies For Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Promising Novel Therapie...
Author: obr
Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Molecular Subtyping Of Pancreatic Cancer
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann Karmanos Cancer Institute, Discusses Molecular SubTyping Of P...
Author: obr
Added: 01/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Pre-Operative Therapy In Resectable Pancreatic Cancer
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer Center, discusses Pre-Operative Therapy In Resec...
Author: obr
Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts
Johanna C. Bendell, MD - Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management
Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - August 8, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
The value of preoperative chemotherapy in pancreatic cancer
Richard Goldberg, MD, on preoperative chemotherapy in pancreatic cancer and whether the PREOPANC-1 has influenced the path of treatment
Author: obr
Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2018 Category: Cancer & Oncology Source Type: podcasts
No One Else is Focusing on Pancreatic Cancer | Answer What Makes Biology of Pancreatic Cancer Unique
Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, explains how No One Else is Focusing on Pancreatic Cancer | Answer What Makes Biology of Pancreatic Cancer Unique
Author: Cancer-News
Added: 07/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Focuses on Frontline Metastatic Pancreatic Cancer | Patients Get Added Benefits of Investigational Agents
Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, explains that the study Focuses on Frontline Metastatic Pancreatic Cancer | Patients Get Added Benefits of Investigational Agents.
Author: Cancer-News
Added: 07/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Lead Investigator of Study is, Dr. Vonderheide | Develop New Agents to help Pancreatic Cancer Patients
Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, talks about Lead Investigator of Study, Dr. Vonderheide | Develop New Agents to help Pancreatic Cancer Patients
Author: Cancer-News
Added: 07/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Gemcitabine + Abraxane - Standard for Pancreatic Cancer | Investigational Agents - Nivolumab-Anti-PD1 & Anti-CD40
Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, explains the combination of Gemcitabine + Abraxane - Standard for Pancreatic Cancer | Investigational Agents - Nivolumab-Anti-PD1 & Anti...
Author: Cancer-News
Added: 07/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2018 Category: Cancer & Oncology Source Type: podcasts
